Dominique McCormick

DR

If you made any changes in Pure these will be visible here soon.

Network

Oliver Lin

Person: Academic: Research Active (Research Assistant)

Peter Tennant

Person: Academic: Research Active (Research Assistant)

Eleanor Gaunt

Person: Academic: Research Active (Research Assistant)

Anna Raper

Person: Academic: Research Active (Research Assistant)

Nick Polydorides

Person: Academic: Research Active

Uta Griesenbach

  • United Kingdom Cyst Fibrosis Gene Therapy Consort
  • UK CF Gene Therapy Consortium
  • National Heart and Lung Institute
  • Imperial College London
  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

J. Alastair Innes

  • United Kingdom Cyst Fibrosis Gene Therapy Consort
  • Univ Edinburgh, University of Edinburgh, Western Gen Hosp, Med Genet Sect, Ctr Mol Med,MRC Inst Genet & Mol Med
  • UK CF Gene Therapy Consortium
  • Molecular Genetics, Medical Biology Section
  • MRC Institute of Genetics and Molecular Medicine
  • University of Edinburgh
  • Western General Hospital
  • Univ Edinburgh, University of Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Med Genet Sect,Ctr Mol Med
  • UK CF Gene Therapy Consortium, University of Edinburgh
  • University of Edinburgh
  • University of Oxford
  • Univ Edinburgh, University of Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Genet Sect,Ctr Mol Med,MRC

External person

Jane C Davies

  • United Kingdom Cyst Fibrosis Gene Therapy Consort
  • UK CF Gene Therapy Consortium
  • National Heart and Lung Institute
  • Royal Brompton and Harefield NHS Foundation Trust
  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Eric W F W Alton

  • Imperial College London
  • University of Oxford
  • United Kingdom Cyst Fibrosis Gene Therapy Consort
  • UK CF Gene Therapy Consortium
  • National Heart and Lung Institute
  • University of Dundee

External person

Stephanie G. Sumner-Jones

  • Gene Medicine Research Group, Nuffield Division Of Clinical Laboratory Sciences, University of Oxford, Oxford, UK

External person

Walter Johnstone

  • University of Strathclyde

External person

Deborah R Gill

  • Univ Oxford, University of Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Gene Med Grp
  • UK CF Gene Therapy Consortium
  • Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Nuffield Division of Clinical Laboratory Sciences
  • University of Oxford
  • Gene Medicine Research Group, Nuffield Division Of Clinical Laboratory Sciences, University of Oxford, Oxford, UK

External person

Stephen C Hyde

  • Univ Oxford, University of Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Gene Med Grp
  • UK CF Gene Therapy Consortium
  • Gene Medicine Research Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Nuffield Division of Clinical Laboratory Sciences
  • University of Oxford
  • Gene Medicine Research Group, Nuffield Division Of Clinical Laboratory Sciences, University of Oxford, Oxford, UK

External person

Cuixiang Meng

  • United Kingdom Cyst Fibrosis Gene Therapy Consort
  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Johan Nilsson

  • University of Southampton
  • Univ Southampton, University of Southampton, Optoelect Res Ctr

External person

Samia Soussi

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Stephen C. Hyde

  • United Kingdom Cyst Fibrosis Gene Therapy Consort
  • Univ Oxford, University of Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Gene Med Grp
  • Old Dominion University

External person

John Black

  • Rolls-Royce plc
  • Rolls Royce PLC, Rolls-Royce Holding Group, Test & Measurement Engn

External person

Yutong Feng

  • University of Southampton
  • Univ Southampton, University of Southampton, Optoelect Res Ctr

External person

Tracy E Higgins

  • United Kingdom Cyst Fibrosis Gene Therapy Consort
  • UK CF Gene Therapy Consortium
  • Department of Gene Therapy
  • National Heart and Lung Institute
  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Ian R Armstrong

  • Royal Infirmary Edinburgh
  • University of Strathclyde

External person

Ian A. Pringle

  • Gene Medicine Research Group, Nuffield Division Of Clinical Laboratory Sciences, University of Oxford, Oxford, UK

External person

Ronald K. Scheule

  • Genzyme, a Sanofi Company, Framingham, MA, USA

External person

Deborah R. Gill

  • United Kingdom Cyst Fibrosis Gene Therapy Consort
  • Univ Oxford, University of Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Gene Med Grp

External person

Seng H. Cheng

  • Department of Rare Diseases Science
  • Genzyme, A Sanofi Company
  • Genzyme, a Sanofi Company, Framingham, MA, USA

External person

Gwyneth Davies

  • Swansea University
  • University of Glasgow
  • Univ London Imperial Coll Sci Technol & Med, Imperial College London, Hammersmith Hosp, Natl Heart & Lung Inst
  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Thomas Benoy

  • University of Strathclyde

External person

Gina Rivellini

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Andrea Munsterberg

  • University of East Anglia

External person

Michael Lengden

  • University of Strathclyde

External person

E. W. Alton

  • Imperial College London
  • UK CF Gene Therapy Consortium, University of Edinburgh
  • Royal Brompton Hosp, Imperial College London
  • UK Cyst Fibrosis Gene Therapy Consortium

External person

Duncan M Geddes

  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Khouler Khan

  • University of Southampton

External person

Mario Chan

  • United Kingdom Cyst Fibrosis Gene Therapy Consort
  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Maria P Limberis

  • University of Pennsylvania

External person

R. K. Scheule

  • Genzyme Corp

External person

Hazel Milligan

  • Western General Hospital

External person

Rosa P Ureta

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Krikor Ozanyan

  • The University of Manchester

External person

Clare J Saunders

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

I. A. Pringle

  • University of Oxford
  • Univ Oxford, University of Oxford, John Radcliffe Hosp, NDCLS, Gene Med Res Grp
  • UK Cyst Fibrosis Gene Therapy Consortium

External person

Michael D Waller

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Diana Bilton

  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Joseph Jacob

  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Paul Lloyd-evans

  • NHS Blood and Transplant

External person

June Brand

  • Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

External person

David K Armstrong

  • Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

External person

D. R. Gill

  • Univ Oxford, University of Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Gene Med Grp
  • UK CF Gene Therapy Consortium, University of Edinburgh
  • University of Oxford

External person

Natalie S Dwyer

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Dan Hewak

  • University of Southampton

External person

Kamila M Pytel

  • Imperial College London
  • UK Cyst Fibrosis Gene Therapy Consortium
  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Emma K Punch

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Emma J Spearing

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

S. C. Hyde

  • Univ Oxford, University of Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Gene Med Grp
  • UK CF Gene Therapy Consortium, University of Edinburgh
  • University of Oxford
  • Univ Oxford, University of Oxford, John Radcliffe Hosp, NDCLS, Gene Med Res Grp
  • UK Cyst Fibrosis Gene Therapy Consortium

External person

Junfang Song

  • University of Dundee

External person

Paula Carvelli

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Andrew G. Nicholson

  • Department of Histopathology, Royal Brompton Hospital, London, UK. a.nicholson@rbh.nthames.nhs.uk
  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Najwa Soussi

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Fuqiang Jia

  • University of Southampton

External person

Stephen N Smith

  • Univ Oxford, University of Oxford, John Radcliffe Hosp, Dept Clin Neurol, FMRIB Ctr
  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Brian F Keogh

  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Katie J Bayfield

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Samantha L Hodges

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Jemyr Gavino

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Tina Osadolor

  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Minna Turkkila

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

S. H. Cheng

  • Genzyme Corp

External person

Lee A Davies

  • University of Oxford
  • Gene Medicine Research Group, Nuffield Division Of Clinical Laboratory Sciences, University of Oxford, Oxford, UK

External person

Javier Parra-Leiton

  • Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

External person

Roberto Calcedo

  • University of Pennsylvania

External person

Paul Bastock

  • University of Southampton

External person

Nicholas J Simmonds

  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Jackie Donovan

  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

T. Higgins

  • Imperial College London
  • University of Oxford
  • UK Cyst Fibrosis Gene Therapy Consortium

External person

Rosanna F Featherstone

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Nancy Jones

  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Hala I Elgmati

  • Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

External person

Marguerite Y. Wasowicz

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Sabrina Gea-sorli

  • Imperial College London
  • UK Cyst Fibrosis Gene Therapy Consortium
  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Johannes Wittig

  • University of East Anglia

External person

Michael Lengden

  • University of Strathclyde

External person

Michelle C Manvell

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Paul Wolstenholme-hogg

  • Genzyme, a Sanofi Company, Framingham, MA, USA

External person

Deborah Ashby

  • Wolfson Inst. of Preventive Medicine
  • Queen Mary University of London

External person

Andrew P. Greening

  • Western Gen Hosp, University of Edinburgh, ECNO
  • Western General Hospital

External person

Sarah Sheard

  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

U. Griesenbach

  • Imperial College London
  • UK CF Gene Therapy Consortium, University of Edinburgh
  • University of Oxford
  • UK Cyst Fibrosis Gene Therapy Consortium

External person

David M Hansell

  • Royal Brompton Hosp, Imperial College London, Dept Radiol
  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Alexandra L Quittner

  • Department of Psychology, University of Miami, Miami, FL, USA

External person

M Angeles Montero

  • Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.

External person

Emily V Bloomfield

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Ruaridh Buchan

  • Western General Hospital

External person

Graciela A Nunez-Alonso

  • Univ Oxford, University of Oxford, John Radcliffe Hosp, NDCLS, Gene Med Res Grp

External person

Laura J Moyce

  • Gene Medicine Research Group, Nuffield Division Of Clinical Laboratory Sciences, University of Oxford, Oxford, UK

External person

Katharine Harman

  • Department of Gene Therapy, Faculty of Medicine, Imperial College, London, UK.

External person

Stephanie Summer-Jones

  • Univ Oxford, University of Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Gene Med Grp

External person

Maria H Dewar

  • Western General Hospital

External person